Canadian Consensus Conference on Coronary Thrombolysis. Recommendations.
D000075202:Contraindications; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000592:standards*
D005343:Fibrinolytic Agents